Our expert attending
Dedicated professionals committed to clinical excellence.
Meet Southern Star Research at BIO Asia–Taiwan 2026
Southern Star Research is proud to attend BIO Asia–Taiwan 2026, one of Asia’s premier biotechnology and life sciences events, bringing together global innovators, investors, pharmaceutical companies, biotech organisations, researchers and service providers to shape the future of healthcare.
The event features an internationally recognised conference program, partnering meetings, company presentations, scientific symposia, workshops and a large-scale biotechnology exhibition, creating valuable opportunities for collaboration across the global clinical development ecosystem.
If your organisation is advancing a promising therapeutic candidate and planning the next stage of clinical development, we look forward to connecting with you in Taipei.
Accelerating Clinical Development Across Asia-Pacific
Through our strategic partnership with Expecto Health Sciences, Southern Star Research provides sponsors with enhanced access to clinical trial expertise, operational capabilities and site networks across Asia.
Together, we support biotechnology and pharmaceutical companies seeking efficient pathways to generate high-quality clinical data while navigating the unique regulatory and operational requirements of the Asia-Pacific region.
Whether you are evaluating first-in-human studies, proof-of-concept programs or multi-country clinical trials, our combined expertise helps sponsors accelerate development with confidence.
Why Sponsors Choose Southern Star Research
As a mid-sized CRO with deep early-phase expertise, we offer:
- Strong experience in complex, mechanism-driven trials
- Regulatory insight across the FDA, EMA, PMDA, and Health Canada
- Established site networks and patient access across APAC
- A delivery model that balances speed, cost efficiency, and data quality
Our focus is simple: to generate high-quality data that supports confident decisions, whether progressing to later phases, securing partnerships, or raising capital.
A Proven Partner for Emerging Biotech and Global Sponsors
From first-in-human studies through to proof-of-concept and later-phase programs, Southern Star Research helps sponsors navigate complex clinical development challenges with scientific rigour, operational excellence and a collaborative approach.
Our therapeutic expertise spans multiple indications, including oncology, neuroscience, rare diseases, metabolic disorders, infectious diseases and medical devices.
By combining regional knowledge with global standards, we help sponsors achieve faster, smarter clinical development outcomes.
Connect With Us at BIO Asia–Taiwan 2026
If you are advancing a biotechnology, pharmaceutical or medical device program and planning your next clinical milestone, we’d welcome the opportunity to discuss your development strategy.
Meet with our Head of Asia during BIO Asia–Taiwan 2026 to explore how Southern Star Research and Expecto Health Sciences can support your clinical program through a more responsive, insight-led CRO model.
Book a meeting today to discuss your clinical development goals and discover how we can help accelerate your path to market.